We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Showcases Innovative PCR Lab Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 13 Nov 2022

Tianlong Science and Technology (Shaanxi, China) is showcasing its integrated PCR lab solution that empowers laboratories at the MEDICA 2022 International Trade Fair being held on November 14-17 in Düsseldorf, Germany. More...

Tianlong provides an innovative PCR lab solution from sample processing system, nucleic acid extractor, and PCR systems to compatible reagents, which has been accredited by many clients for its great performance and high stability. Within its integrated PCR lab solution being showcased at this year’s edition of MEDICA, is the Libex Nucleic Acid Extractor that can overcome the shortcomings of conventional nucleic acid extraction methods and achieve rapid and efficient sample preparation. With the appropriate nucleic acid extraction reagents, it can process serum, plasma, whole blood, swabs, amniotic fluid, feces, tissue and tissue lavage, paraffin sections, bacteria, fungi and other sample types. Also on display at the event is Tianlong’s new GeneMix Pro automatic sample processing system. Designed for automating laboratory workflow, GeneMix Pro can process 96 samples within 20 minutes and free professionals from tedious mechanical operations.

At MEDICA 2022, Tianlong is also highlighting the PANA S401/S201 automated pipetting workstation which is designed as an important tool for PCR setup and automates tedious, error-prone manual tasks, provides consistent sample mixing, and excellent pipetting performance to standardize results. In addition, visitors to Tianlong’s booth at MEDICA 2022 can experience the Gentier96E real time PCR detection system designed to meet the experimental needs of high-end users. Gentier96E offers various advantages including advanced efficient temperature control system and photoelectric system, powerful and easy-to-use software analysis function, and user-friendly control method, etc. It can easily process downstream multiplex gene detection, quantitative analysis, SNP analysis, dissociation curve analysis and other applications.

Tianlong is also demonstrating the Gentier 48 Real-time PCR System which is specially designed for small and medium-sized laboratories, mobile laboratories, field testing professionals and so on, to support absolute quantitative analysis, relative quantitative analysis, isothermal amplification, dissociation curve analysis, genotyping, and endpoint fluorescence analysis, etc. Alongside the Gentier 48, Tianlong is demonstrating the Gentier Mini portable Real-Time PCR System that is designed to meet the increasing needs for on-site and rapid testing. The Gentier Mini is compact and portable, easy to use, and highly efficient in real-time PCR testing with accurate temperature control, enabling real-time PCR tests out of the lab for all types of fields for various applications.

Related Links:
Tianlong Science and Technology 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.